failure compared to placebo, but when this is seen with no demonstrable dose response it calls the reliability of this finding into question. Of most striking impact was a significantly lower all-cause mortality over the 14 day observation period after starting the treatment period in the four active groups compared to placebo (11·7% compared to 19·6%, P=0·031). Yet again no dose response was seen. There were borderline effects on symptomatic status and patient self-assessments. No consistent effect was seen for objective signs of worsening cardiac function, however.
Perhaps the most convincing effect was a significant reduction in the need for additional heart failure therapy, as would be expected for an effective therapy for the acutely failing heart. Does this study alone require us to consider this a proven therapy for acute heart failure complicating myocardial infarction? The answer is definitely no. It does, however, give valuable information on the safety and tolerability of an effective positive inotropic therapy that appears at least unlikely in the short term to increase mortality. The benefits were seen with an increase in hypotension and ischaemia only in the highest dose group. Does this make us revisit the possibility of acute pharmacological inotropic support in acute transient heart failure with the calcium sensitizers? Here more of an argument can be made. Particularly in the modern era of beta-blockade in heart failure the risk/benefit ratio of positive inotropic agents may be different if the myocardium is protected by betablockers, a situation we are much more likely to see in the future [10] . One must be careful, of course, given the evidence for selection bias in reporting positive as opposed to negative trials in heart failure
[11] that we do not exaggerate the significance of these findings. It does tell us, however, that more rather than fewer clinical trials of acute heart failure are needed, and that the positive inotropes may still earn their evidence-based credentials in certain circumstances. Just as art historians dissect the colours, the pigments and the brushstrokes in paintings, the best histopathologists avoid an immediate diagnosis, analysing the nature of the tissue types in the section and the appearance of the cellular infiltrates before reaching a conclusion. In this way, the provenance of paintings is established and new histological diagnoses evolve. For several decades, pathologists failed to recognise Helicobacter pylorii in gastric biopsies and until the advent of immunohistology, overlooked the obvious lymphocytic infiltrates in atheromatous plaques. We had probably recognized that rupture of the cap of an atheromatous plaque was the stimulus to coronary thrombosis but detailed descriptions of this important change only appeared in the 1980s [1, 2] . Plaque rupture usually occurs when the atheromatous lesion is eccentric and contains a large core of lipid. The concept of plaque rupture is now widely accepted and has been incorporated into the so-called 'Starry system' of classifying atheromatous lesions [3] and its more recent modification by Virmani et al. [4] . Recent histological studies suggest that multiple subclinical episodes of plaque rupture, followed by healing, are an important mechanism for the growth of atheromatous lesions. Burke and his colleagues studied men who died of sudden coronary death and looked specifically for evidence of healed rupture sites and multilayering of the collagenous cap within lesions [5] . Thirty-three of 44 patients who died with evidence of acute plaque rupture showed evidence of previous healed rupture. Nine showed three previous healed rupture sites and six showed four. There was a close relationship between the number of previous ruptures and the mean percentage stenosis in the coronary artery. This investigation provides good evidence that plaque rupture is one of the reasons for the progressive enlargement of plaques and has been likened to a form of repeated wound healing.
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A series of investigations in the mid-1990s demonstrated that another mechanism, plaque erosion, was responsible for acute coronary thrombosis in a proportion of patients [6] . This type of lesion has a distinctive histological appearance. The endothelial surface of the affected segment of vessel is ulcerated. The underlying wall has concentric atheromatous disease with little evidence of the lipid pool that is characteristic of plaque rupture. Pathologists at the Armed Forces Institute in Washington D.C. examined the hearts of 113 men with coronary disease who had died suddenly [7] . An acute coronary thrombus was identified in 59 (54%), very much what would be expected from other studies [8] . Forty-one of the 59 thromboses resulted from rupture of a lipid-rich atheromatous plaque and 18 from the erosion of a fibrous plaque. An unusually large amount of clinical information was available in this study. Multivariate analyses demonstrated that abnormal lipid profiles were associated with plaque rupture, whereas cigarette smoking was a strong risk factor for erosion with thrombosis. This group then collaborated with pathologists in Pavia, Italy, in a study that has produced some unique information [9] . The entire epicardial coronary artery tree was retained and serially sectioned in 298 patients who had sustained an acute myocardial infraction but had not received any form of thrombolytic treatment or myocardial revascularization. Acute coronary thrombi were identified in 98% of these patients and in 10% multiple thrombi were present. This careful histological study has set a standard for all practising pathologists and, if it is needed, has provided clear justification for current management strategies in acute myocardial infarction. Seventy-five percent of thrombi occurred over ruptured plaques, whereas 25% were in patients with acute erosions. Plaque erosion was more common in women. Infarct size, the specific artery affected and the multiplicity of thrombi were distributed similarly amongst the two types of lesion. The patients in these studies were largely middle-aged and elderly and there was no clear relationship between age and the nature of the culprit lesion. In this context, a particularly interesting report from the Amsterdam group appears in the current issue [10] . Henriques de Gouveia and her colleagues studied four women and seven men between 24 and 35 years of age who died suddenly of coronary artery disease. In contrast to previous studies, the majority of these (9 out of 11) had plaque erosions whilst only two had ruptures. The authors use a strict definition of sudden cardiac death and there was no evidence of previous symptoms of note in any patient. This group has particular expertise in arterial histology and immunohistochemistry. Their findings and illustrations demonstrate that in only three cases was the thrombus completely fresh, two in ruptured and one in an eroded plaque. In the remaining eight, all erosions, there was histological evidence that pathological changes had occurred days, or even weeks, before the time of death. So just as the Washington group has demonstrated that subclinical rupture has a role in plaque progression, it appears that the same story may be true for plaque erosion. Do these careful histological studies have any immediate clinical relevance? Plaque erosion and plaque rupture appear to be distinct pathological processes but as yet they have not been shown to produce different patterns of clinical disease [9] . The very least that should be done in the future is to determine how they may be distinguished by imaging methods and how they respond to emergency or routine angioplasty and lipid lowering strategies.
